Thu, Nov 21, 2024
[Archive]
Volume 28, Issue 130 (September & October 2020)
J Adv Med Biomed Res 2020, 28(130): 284-290 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Owlia F, Khodaei-ardakani Z, Soleymani saleh-abadi H. Assessment of Different Manifestations of Known Cases of Behçet’s Disease. J Adv Med Biomed Res 2020; 28 (130) :284-290
URL: http://journal.zums.ac.ir/article-1-6033-en.html
URL: http://journal.zums.ac.ir/article-1-6033-en.html
1- Dept. of Oral and Maxillofacial Medicine, School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran ,dr.owlia@gmail.com
3- associated professorDept. of Rheumatology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran ,
3- associated professorDept. of Rheumatology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract: (145140 Views)
Background:
Behçet’s disease (BD) is a multi-system inflammatory vascular disorder with auto immunity background. It is a genetic disease that may be affected by environmental factors. Behçet’s disease may involve different organs like urogenital, skin, eyes and gastrointestinal system. According to geographic area and genetic predisposition, prevalence of the disease is different. The aim of this study was the evaluation of some clinical features of muco-cutaneous lesions of Behcet,s disease in 2018.
Materials and Methods:
This cross-sectional study was done on 43 patients with Behçet’s disease (24 men, 19 women). Data about age, sex, duration of the disease, taking medicine was collected. The self-reported questionnaire was completed by participations. Skin manifestations, genital and ocular involvement were alsodocumented.
Results:
The male to female ratio was 1.26/1. Oral aphthous commonly localized on the lips. The percent for ocular involvement and skin lesions were 76%,48% respectively. There was a statically significant correlation between ocular lesions and age. Also relationship between skin lesions and frequency of oral aphthous per year was meaningful too. There was a significant relationship between incidence of ocular lesions and incidence of skin lesions.
Conclusion:
Oral aphthous as the most popular manifestation of BD is the hallmark of diagnosis. Thus, patients with oral aphthous require close surveillance for other manifestations of BD for timely diagnosis and refer to Rheumatologist.
Behçet’s disease (BD) is a multi-system inflammatory vascular disorder with auto immunity background. It is a genetic disease that may be affected by environmental factors. Behçet’s disease may involve different organs like urogenital, skin, eyes and gastrointestinal system. According to geographic area and genetic predisposition, prevalence of the disease is different. The aim of this study was the evaluation of some clinical features of muco-cutaneous lesions of Behcet,s disease in 2018.
Materials and Methods:
This cross-sectional study was done on 43 patients with Behçet’s disease (24 men, 19 women). Data about age, sex, duration of the disease, taking medicine was collected. The self-reported questionnaire was completed by participations. Skin manifestations, genital and ocular involvement were alsodocumented.
Results:
The male to female ratio was 1.26/1. Oral aphthous commonly localized on the lips. The percent for ocular involvement and skin lesions were 76%,48% respectively. There was a statically significant correlation between ocular lesions and age. Also relationship between skin lesions and frequency of oral aphthous per year was meaningful too. There was a significant relationship between incidence of ocular lesions and incidence of skin lesions.
Conclusion:
Oral aphthous as the most popular manifestation of BD is the hallmark of diagnosis. Thus, patients with oral aphthous require close surveillance for other manifestations of BD for timely diagnosis and refer to Rheumatologist.
Type of Study: Original Article |
Subject:
Clinical medicine
Received: 2020/05/23 | Accepted: 2020/07/14 | Published: 2020/09/21
Received: 2020/05/23 | Accepted: 2020/07/14 | Published: 2020/09/21
References
1. Davatchi F, Chams-Davatchi C, Shams H, et al. Behcet's disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev ClinImmunol. 2017;13(1):57-65. [DOI:10.1080/1744666X.2016.1205486]
2. Alpsoy E. Behcet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620-32. [DOI:10.1111/1346-8138.13381]
3. Esatoglu SN, Kutlubay Z, Ucar D, et al. Behcet's syndrome: providing integrated care. J Multidiscip Health Care2017;10:309-19. [DOI:10.2147/JMDH.S93681]
4. Khabbazi A, KarkonShayan F, Ghojazadeh M, et al. Adherence to treatment in patients with Behcet's disease. Int J Rheumat Dis. 2018;21(12):2158-66. [DOI:10.1111/1756-185X.13109]
5. Kilian NC, Sawalha AH. Behcet's disease in the United States: A single center descriptive and comparative study. Europ J Rheumatol. 2017;4(4):239-44. [DOI:10.5152/eurjrheum.2017.17112]
6. Mat MC, Sevim A, Fresko I, Tuzun Y. Behcet's disease as a systemic disease. ClinDermatol. 2014;32(3):435-42. [DOI:10.1016/j.clindermatol.2013.11.012]
7. Shahriyari E, Bonyadi M, JabbarpoorBonyadi MH, Soheilian M, Yaseri M, Ebrahimiadib N. Ubiquitin associated and SH3 domain containing B (UBASH3B) gene association with Behcet's disease in Iranian population. Curr Eye Res. 2019;44(2):200-5. [DOI:10.1080/02713683.2018.1524913]
8. Scherrer MAR, Rocha VB, Garcia LC. Behcet's disease: review with emphasis on dermatological aspects. Anais brasileiros de dermatologia. 2017;92(4):452-64. [DOI:10.1590/abd1806-4841.20177359]
9. Davari P, Rogers RS, Chan B, Nagler TH, Fazel N. Clinical features of Behcet's disease: A retrospective chart review of 26 patients. J Dermatol Treat. 2016;27(1):70-4. [DOI:10.3109/09546634.2015.1054781]
10. Kiss E, Dohan J, Nemeth J, Poor G. Behcet's disease: a rarely recognized orphan disorder. Orvosihetilap. 2013;154(3):93-101. [DOI:10.1556/OH.2013.29528]
11. Saccucci M, Di Carlo G, Bossu M, Giovarruscio F, Salucci A, Polimeni A. Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management. J Immunol Res. 2018;2018:6061825. [DOI:10.1155/2018/6061825]
12. Munoz SA, Orden AO, Kostianovsky A, et al. The HLA-B*51 allele is strongly associated with Behcet disease in an argentinean population. ReumatolClin. 2020;16(4):282-85 [DOI:10.1016/j.reuma.2018.07.002]
13. Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatol (Oxford, England). 2012;51(5):887-900. [DOI:10.1093/rheumatology/ker428]
14. Ryu HJ, Seo MR, Choi HJ, Baek HJ. Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51. Korean J Int Med. 2018;33(5):1025-31. [DOI:10.3904/kjim.2016.202]
15. Hamzaoui A, Houman MH, Massouadia M, et al. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients. Europ J IntMed. 2012;23(4):347-9. [DOI:10.1016/j.ejim.2011.12.011]
16. Demirseren DD, Ceylan GG, Akoglu G, et al. HLA-B51 subtypes in Turkish patients with Behcet's disease and their correlation with clinical manifestations. Genet Molec Res. 2014;13(3):4788-96. [DOI:10.4238/2014.July.2.8]
17. The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J EuropAcadDermatolVenereol . 2014;28(3):338-47. [DOI:10.1111/jdv.12107]
18. Kanecki K, Nitsch-Osuch A, Gorynski P, Tarka P, Kutera A, Tyszko P. Behcet disease: a rare systemic vasculitis in Poland. Polish archives of internal medicine. 2017;127(10):652-6. [DOI:10.20452/pamw.4160]
19. Wang ZK, Shi H, Wang SD, et al. Confusing untypical intestinal Behcet's disease: Skip ulcers with severe lower gastrointestinal hemorrhage. World J GastrointestEndoscop. 2014;6(1):27-31. [DOI:10.4253/wjge.v6.i1.27]
20. Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Behcet's disease physiopathology: a contemporary review. Auto Immun Highlights. 2016;7(1):4. [DOI:10.1007/s13317-016-0074-1]
21. Taylor J, Glenny AM, Walsh T, et al. Interventions for the management of oral ulcers in Behcet's disease. Cochrane Database System Rev. 2014(9):Cd011018. [DOI:10.1002/14651858.CD011018]
22. Tunes RS, Anjos TC, Martins GB, Barreto ER, Santiago MB. Prevalence of Behcet's syndrome in patients with recurrent aphthous ulcerations in Brazil. Rheumatol Int. 2009;29(8):875-8. [DOI:10.1007/s00296-008-0787-1]
23. Lennikov A, Alekberova Z, Goloeva R, et al. Single center study on ethnic and clinical features of Behcet's disease in Moscow, Russia. ClinRheumatol. 2015;34(2):321-7. [DOI:10.1007/s10067-013-2442-9]
24. Ghembaza ME, Bouabdallah N, Lounici A. Behcet disease in Western Algeria. Medecine et santetropicales. 2017;27(1):101-4. [DOI:10.1684/mst.2017.0656]
25. Bergamo S, di Meo N, Stinco G, Bonin S, Trevisini S, Trevisan G. Adamantiades-Behcet disease at the beginning of the silk route: North-East Italian Experience. ActadermatovenerolCroatica : ADC. 2017;25(4):295-7.
26. Suzuki T, Horita N, Takeuchi M, et al. Clinical features of early-stage possible Behcet's disease patients with a variant-type major organ involvement in Japan. Modern Rheumatol. 2018:1-7.
27. Kim JN, Kwak SG, Choe JY, Kim SK. The prevalence of Behcet's disease in Korea: data from health insurance review and assessment service from 2011 to 2015. Clin Experiment Rheumatol. 2017;35Suppl 108(6):38-42.
28. Sibley C, Yazici Y, Tascilar K, et al. Behcet syndrome manifestations and activity in the United States versus Turkey -- a cross-sectional cohort comparison. J Rheumatol. 2014;41(7):1379-84. [DOI:10.3899/jrheum.131227]
29. Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behcet's disease in the US: a population-based study. Arthritis Rheumatism. 2009;61(5):600-4. [DOI:10.1002/art.24423]
30. Ugurlu N, Bozkurt S, Bacanli A, Akman-Karakas A, Uzun S, Alpsoy E. The natural course and factors affecting severity of Behcet's disease: a single-center cohort of 368 patients. Rheumatol Int. 2015;35(12):2103-7. [DOI:10.1007/s00296-015-3310-5]
31. Cansu DU, Kasifoglu T, Korkmaz C. Do clinical findings of Behcet's disease vary by gender?: A single-center experience from 329 patients. Europ J Rheumatol. 2016;3(4):157-60. [DOI:10.5152/eurjrheum.2016.038]
32. Ozyurt K, Colgecen E, Baykan H. Does familial occurrence or family history of recurrent oral ulcers influence clinical characteristics of Behcet's disease? ActadermatovenerologicaCroatica : ADC. 2013;21(3):168-73.
33. Sula B, Batmaz I, Ucmak D, Yolbas I, Akdeniz S. Demographical and clin characteristics of Behcet's disease in Southeastern Turkey. J Clin Med Res. 2014;6(6):476-81. [DOI:10.14740/jocmr1952w]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
